menu
    • menu

    Company profile for Invizyne

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Invizyne is leading the Cell-Free revolution In Synthetic Biology. Our pioneering SimplePath platform produces natural chemicals by reducing complex cellular processes to their essential elements. Unconstrained by complex cellular metabolism we build simple, flexible and modular production systems that are scalable and efficient.Nature provides us with countless chemicals that can improve our lives. Trees and plants often supp...
    Invizyne is leading the Cell-Free revolution In Synthetic Biology. Our pioneering SimplePath platform produces natural chemicals by reducing complex cellular processes to their essential elements. Unconstrained by complex cellular metabolism we build simple, flexible and modular production systems that are scalable and efficient.Nature provides us with countless chemicals that can improve our lives. Trees and plants often supply them, but in such small amounts that they’re hard to extract, leading to waste and environmental degradation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InvizyneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    140 W Chestnut Ave Monrovia​, CA, 91016-3412
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.invizyne.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    eXoZymes Joins $9M NSF Cell-Free Bio Program
    eXoZymes Joins $9M NSF Cell-Free Bio Program

    26 Jun 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/exozymes-selected-as-core-industry-partner-in-9m-nsf-funded-initiative-to-advance-mod-1043483

    ACCESSWIRE
    26 Jun 2025
    Share Share
    eXoZymes & MDB Capital Announce Leadership Transition at eXoZymes
    eXoZymes & MDB Capital Announce Leadership Transition at eXoZymes

    21 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/21/3030697/0/en/eXoZymes-and-MDB-Capital-Announce-Leadership-Transition-at-eXoZymes-Inc.html

    GLOBENEWSWIRE
    21 Feb 2025
    Share Share
    Invizyne Tech Announces Name Change to eXoZymes
    Invizyne Tech Announces Name Change to eXoZymes

    10 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/10/3023585/0/en/Invizyne-Technologies-Announces-Name-Change-to-eXoZymes-Inc-and-New-Ticker-Symbol.html

    GLOBENEWSWIRE
    10 Feb 2025
    Share Share
    Invizyne Technologies for $2M Project to Advance Aviation Fuel
    Invizyne Technologies for $2M Project to Advance Aviation Fuel

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2983722/0/en/Invizyne-Technologies-Selected-for-2-Million-Project-to-Advance-Sustainable-Aviation-Fuel-Capabilities.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share
    Invizyne Technologies Announces Closing of Initial Public Offering
    Invizyne Technologies Announces Closing of Initial Public Offering

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981583/0/en/Invizyne-Technologies-Announces-Closing-of-Initial-Public-Offering.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
    Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing

    13 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/13/2980648/0/en/Invizyne-s-Nasdaq-IPO-Marks-New-Era-of-Biomanufacturing.html

    GLOBENEWSWIRE
    13 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search